Cargando…
Ebselen, Disulfiram, Carmofur, PX-12, Tideglusib, and Shikonin Are Nonspecific Promiscuous SARS-CoV-2 Main Protease Inhibitors
[Image: see text] Among the drug targets being investigated for SARS-CoV-2, the viral main protease (M(pro)) is one of the most extensively studied. M(pro) is a cysteine protease that hydrolyzes the viral polyprotein at more than 11 sites. It is highly conserved and has a unique substrate preference...
Autores principales: | Ma, Chunlong, Hu, Yanmei, Townsend, Julia Alma, Lagarias, Panagiotis I., Marty, Michael Thomas, Kolocouris, Antonios, Wang, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American
Chemical Society
2020
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7571300/ https://www.ncbi.nlm.nih.gov/pubmed/33330841 http://dx.doi.org/10.1021/acsptsci.0c00130 |
Ejemplares similares
-
Ebselen, disulfiram, carmofur, PX-12, tideglusib, and shikonin are non-specific promiscuous SARS-CoV-2 main protease inhibitors
por: Ma, Chunlong, et al.
Publicado: (2020) -
Repurposing Auranofin, Ebselen, and PX-12 as Antimicrobial Agents Targeting the Thioredoxin System
por: May, Holly C., et al.
Publicado: (2018) -
Structure and inhibition of the SARS-CoV-2 main protease reveals strategy for developing dual inhibitors against M(pro) and cathepsin L
por: Sacco, Michael Dominic, et al.
Publicado: (2020) -
Structure and inhibition of the SARS-CoV-2 main protease reveal strategy for developing dual inhibitors against M(pro) and cathepsin L
por: Sacco, Michael Dominic, et al.
Publicado: (2020) -
Synergistic Inhibition of SARS-CoV-2 Replication
Using Disulfiram/Ebselen and
Remdesivir
por: Chen, Ting, et al.
Publicado: (2021)